Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma

“…Upper tract urothelial carcinomas (UTUC) are relatively rare and account for only 5-10% of UCs, but are common in Taiwan (3). Its behavior appears multi-focal and in 17% of cases, concurrent bladder cancer is present (4). Furthermore, an estimated 22-47% of patients with UTUC may suffer from bladder recurrence (5) and 2-6% of patients suffer from contralateral recurrence (6).…”

mentioning

confidence: 99%

Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma

Hung

Wang

Yang

et al. 2017

View full text Add to dashboard Cite

“…In 17% of the cases, concomitant bladder tumors are present [5]. Synchronous bilateral UTUC is rare and has been reported in 0.8-4.7% of the cases [4,6,7].…”

Section: Discussionmentioning

confidence: 99%

A Case of Synchronous Bilateral Upper Urinary System Urothelial Carcinoma

Buldu¹,

Kurt²,

Inan³

et al. 2016

Ann Clin Anal Med

View full text Add to dashboard Cite

ÖzetÜretelyal kanserler insanda 4.en sık görülen tümörler olmasına rağmen senkronize bilateral üst üriner sistem üretelyal kanseri (UTUC) oldukça nadir görülmekte-dir. Yüksek riskli unilateral UTUC olan hastalarda radikal nefroüreterektomi (RNU) gold standart tedavi yöntemidir. Fakat senkronize bilateral UTUC için tedavi yön-temi konusunda bir konsensüs mevcut değildir. Hasta ve tümörün değerlendirme-sine göre karar verilmesi önerilmiştir. Bu vakada 53 yaşında senkronize bilateral yüksek riskli UTUC ile başvuran hastaya bilateral nefron koruyucu yöntem (NSS) uygulanmış ve sonuçları ortaya konulmuştur. Anahtar KelimelerSenkronize; Bilateral Üst Üriner Sistem; Ürotelyal Kanser; Tedavi AbstractSynchronous bilateral upper urinary tract urothelial cancer (UTUC) is a very rare form of urothelial cancer. In patients with high-risk unilateral UTUC, radical nephroureterectomy (RNU) is the gold standard treatment. However, there is no consensus on the treatment for synchronous bilateral UTUC. Evaluation of the patient and the tumor is recommended. Bilateral nephron-sparing surgery (NSS) was performed on a 53-year-old patient who presented with high-risk synchronous bilateral UTUC, and the outcome was reported.

show abstract

Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma

Abstract: Our findings suggest that the possibility of concomitant BC in primary diagnosed patient with UUT-UCC is as high as 33 % and mainly depends on upper tract tumor location.

Cited by 141 publications

References 29 publications

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma

A Case of Synchronous Bilateral Upper Urinary System Urothelial Carcinoma

Contact Info

Product

Resources

About